PHS
CTLT

PFM Health Sciences’s CATALENT, INC. CTLT Stock Holding History

PFM Health Sciences’s Portfolio CTLT Stock Details CTLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-218,366
Closed -$23.4M – 92
2022
Q2 		$23.4M Sell
218,366
-37,730
-15% -$3.84M 0.89% 43
2022
Q1 		$28.4M Sell
256,096
-70,604
-22% -$7.37M 1.06% 40
2021
Q4 		$41.8M Buy
326,700
+148,900
+84% +$19.1M 1.42% 33
2021
Q3 		$23.7M Buy
+177,800
New +$22.2M 0.7% 49
2020
Q1 		– Sell
-316,962
Closed -$17.8M – 81
2019
Q4 		$17.8M Sell
316,962
-789,811
-71% -$40.3M 0.85% 38
2019
Q3 		$52.7M Buy
1,106,773
+489,754
+79% +$26.3M 1.56% 24
2019
Q2 		$33.4M Buy
+617,019
New +$28.3M 0.64% 52

Other funds holding CTLT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PFM Health Sciences's CTLT Position: Q3 2022 in Review

PFM Health Sciences sold out of CATALENT, INC. (CTLT) in Q3 2022, closing a stake of 218,366 shares — an estimated $23.4M sold.

PFM Health Sciences first reported a position in CTLT in Q2 2019 and held it in 7 quarters. The position peaked at $52.7M in Q3 2019. 507 funds tracked by Wall St. Rank hold CTLT as of Q3 2022.

  • PFM Health Sciences reported no remaining CATALENT, INC. position as of Q3 2022 after selling out during the quarter.
  • PFM Health Sciences sold 218,366 CATALENT, INC. shares in Q3 2022, an estimated $23.4M.
  • PFM Health Sciences first reported a position in CATALENT, INC. in Q2 2019 and held it in 7 quarters.
  • PFM Health Sciences's CATALENT, INC. position peaked at $52.7M in Q3 2019.
  • 507 funds tracked by Wall St. Rank held CATALENT, INC. as of Q3 2022.

Based on PFM Health Sciences's 13F filing for Q3 2022, filed 14 Nov 2022.